The second study aimed to investigate the impact of hepatitis C testing on injecting risk behaviour by opiate using IDUs. Participants were recruited opportunistically through contacts with drug treatment services in Manchester and rural northwest Wales, and had either received a positive or a negative HCV antibody test result, or had never been tested. Forty three semi-structured interviews were carried out using topic areas of drug use patterns, current and past injecting behaviour, and experience and knowledge of HCV testing. Four focus groups were also held with IDUs, two in each setting. Incentives of £20 supermarket vouchers plus travel expenses were provided. Data were analysed using the inductive framework approach. The findings showed that having a negative HCV result could lead to more careful injecting risk behaviour or maintaining current safer injecting practices, however the impact of having an awareness of either a positive or negative HCV status on injecting risk behaviour could be superseded by issues such as whether the person was experiencing withdrawal symptoms, or whether clean injecting equipment was available. There was inadequate pre and post-test counselling provision in both study areas. The authors state that they failed to demonstrate that knowledge of a positive HCV test result reduces injecting risk behaviour and suggest that improved pre and post-test counselling could have an impact on injecting risk behaviour.